---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-004117"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:33:02.289905+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CareDx prelim Q4 rev $81.9-82.2M (+4% YoY); FY22 rev ~$321M (+8%); $50M buyback authorized

## Summary
- Preliminary Q4 2022 revenue $81.9-82.2M vs $79.2M in Q4 2021; testing services rev $64.9-65.2M (down from $68.6M).
- Patient testing volume ~47,700 (+14% YoY), including ~2,300 AlloSure Lung tests.
- Authorized $50M share buyback; cash & equivalents ~$292M with no debt.
- Patient and digital solutions rev $28.8M in FY22 vs $10.3M in FY21, a 180% increase.
- CEO targets adjusted EBITDA profitability in H1 2023; full guidance on Feb 2023 call.

## SEC filing metadata
- accession: 0001193125-23-004117
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000119312523004117/0001193125-23-004117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000119312523004117/d443407d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-004117
- JSON: https://secwatch.observer/filing/0001193125-23-004117.json
- Plain text: https://secwatch.observer/filing/0001193125-23-004117.txt

## Key facts
- Earnings Releases
  CareDx, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $81.9 million to $82.2 million.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $81.9 million to $82.2 million
  - Result: preliminary results
  source text: Preliminary revenue for the three months ended December 31, 2022, is expected to be between $81.9 million and $82.2 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000119312523004117/0001193125-23-004117-index.htm
- Earnings Releases
  CareDx, Inc. reported the full year ended December 31, 2022 results: revenue $321.3 million to $321.6 million.
  - Period: the full year ended December 31, 2022
  - Revenue: $321.3 million to $321.6 million
  - Result: preliminary results
  source text: Preliminary revenue for the full year ended December 31, 2022, is expected to be between $321.3 million and $321.6 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000119312523004117/0001193125-23-004117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.